![]() |
市場調查報告書
商品編碼
1755383
體脂測量市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Body Fat Measurement Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024年,全球體脂測量市場規模達8.83億美元,預計到2034年將以7.8%的複合年成長率成長,達到19億美元,這得益於全球對健康、健身和早期疾病檢測日益成長的關注。體脂測量在評估人體健康狀況方面發揮著至關重要的作用,因為它有助於確定體內脂肪與瘦體重的比例。準確測量體脂肪對於控制肥胖、心血管疾病、糖尿病和代謝性疾病等疾病至關重要。這些疾病通常是由於荷爾蒙失衡和新陳代謝失調而導致脂肪異常堆積。此類疾病的發生率不斷上升,對可靠的診斷工具的需求也日益成長。
技術進步,尤其是生物電阻抗分析領域的進步,進一步促進了市場的發展。這些設備提供了一種非侵入性、經濟高效且準確的方法來追蹤身體組成指標,例如脂肪百分比、水分含量和肌肉量。隨著消費者意識和醫療保健體系的不斷發展,全球對使用者友善且精準的脂肪測量解決方案的需求日益成長。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 8.83億美元 |
預測值 | 19億美元 |
複合年成長率 | 7.8% |
生物阻抗分析儀市場在2024年實現了2.713億美元的收入,預計到2034年將以9.1%的複合年成長率快速成長。這類分析儀之所以受歡迎,源自於其價格實惠、易於使用和快速評估能力。隨著全球肥胖危機加劇,尤其是在城市地區,常規的身體組成追蹤已變得越來越普遍。這些分析儀現已成為臨床、健身和健康領域不可或缺的一部分。整合多頻掃描、藍牙支援和智慧型手機應用程式等先進功能,提升了其功能性,提高了準確性,增強了用戶參與度,預計將推動其在更廣泛人群中的進一步普及。
2024年,醫院細分市場收入達3.197億美元,佔36.2%,這得益於臨床環境中對精準健康評估的持續需求。醫院通常會投資雙能量X光吸收儀和空氣置換體積描記法等高階技術,用於高階身體組成分析,進而提高診斷準確性和病患管理水準。這些設施是大多數患者的初始照護端,並進行一般評估和術前評估,從而增加了脂肪測量程序的頻率。
預計到2034年,北美體脂測量市場規模將達到6.084億美元,其中美國將位居榜首,到2024年將達到2.647億美元。全球肥胖水準的顯著上升是加速採用先進診斷解決方案的主要因素。隨著預防性醫療保健意識的不斷提高,體脂分析擴大被納入日常保健和臨床工作流程中。美國高度重視技術創新和公共衛生計劃,因此仍然是推動市場擴張的關鍵地區。
塑造全球體脂測量市場的關鍵產業參與者包括 InBody、AccuFitness、歐姆龍醫療、百利達株式會社、DMS Imaging、Hologic、COSMED、GE HealthCare Technologies、Maltron International、L'Acn Srl. 和 Beurer。為了提升市場地位,各公司紛紛採取創新驅動策略。許多公司正在投資研發,以開發結合人工智慧演算法和行動整合的更精準、更人性化的設備。製造商也拓展其產品組合,推出集脂肪測量、肌肉測量、水分監測和代謝監測於一體的多功能分析儀。與醫療機構和健康中心的策略合作,使產品在臨床和消費者領域得到更廣泛的應用。此外,各公司正在加強全球分銷管道,並為專業人士提供培訓項目,以增強用戶信心並提高產品採用率。
The Global Body Fat Measurement Market was valued at USD 883 million in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 1.9 billion by 2034, driven by the rising global focus on health, fitness, and early disease detection. Body fat measurement plays a crucial role in assessing a person's health, as it helps determine the ratio of fat to lean mass in the body. Accurate measurement of body fat is important for managing conditions such as obesity, cardiovascular disorders, diabetes, and metabolic diseases. These disorders often result in abnormal fat accumulation due to hormonal imbalances and disrupted metabolism. The increasing incidence of such conditions has created a consistent demand for reliable diagnostic tools.
Technological advancements, particularly in bioelectrical impedance analysis, have further contributed to the market's momentum. These devices offer a non-invasive, cost-effective, and accurate approach to tracking body composition metrics such as fat percentage, hydration levels, and muscle mass. As consumer awareness and healthcare systems evolve, the demand for user-friendly and precise fat measurement solutions rises globally.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $883 Million |
Forecast Value | $1.9 Billion |
CAGR | 7.8% |
The bioimpedance analyzers segment generated USD 271.3 million in 2024 and is expected to witness rapid growth at a CAGR of 9.1% through 2034. Their popularity stems from their affordability, ease of use, and quick assessment capabilities. With the global obesity crisis intensifying, especially in urban areas, routine tracking of body composition has become more common. These analyzers are now integral in clinical, fitness, and wellness environments. Integrating advanced features such as multi-frequency scanning, Bluetooth support, and smartphone apps has elevated their functionality, improving accuracy and enhancing user engagement is expected to drive further adoption across a wide demographic.
The hospitals segment generated USD 319.7 million in 2024 and captured a 36.2% share supported by the consistent demand for precise health assessments in clinical settings. Hospitals typically invest in high-end technologies like dual-energy X-ray absorptiometry and air displacement plethysmography for advanced body composition analysis, improving diagnostic accuracy and patient management. These facilities act as the initial point of care for most patients and conduct general and preoperative evaluations, increasing the frequency of fat measurement procedures.
North America Body Fat Measurement Market is projected to hit USD 608.4 million by 2034, with the U.S. leading at USD 264.7 million in 2024. The significant rise in obesity levels globally is a primary factor accelerating the adoption of advanced diagnostic solutions. As awareness around preventive healthcare continues to rise, body fat analysis is increasingly incorporated into wellness routines and clinical workflows. With a strong focus on technological innovation and public health initiatives, the U.S. remains a critical region contributing to market expansion.
Key industry players shaping the Global Body Fat Measurement Market include InBody, AccuFitness, Omron Healthcare, Tanita Corporation, DMS Imaging, Hologic, COSMED, GE HealthCare Technologies, Maltron International, L'Acn Srl., and Beurer. To enhance their market position, companies are embracing innovation-driven strategies. Many are investing in R&D to develop more accurate and user-friendly devices incorporating AI algorithms and mobile integration. Manufacturers are also broadening their product portfolios to include multi-functional analyzers that combine fat measurement with muscle, hydration, and metabolic tracking. Strategic collaborations with healthcare providers and wellness centers allow broader product adoption across clinical and consumer segments. Additionally, firms are strengthening global distribution channels and offering training programs for professionals to boost user confidence and drive adoption rates.